POTASSIUM CHLORIDE 15% = KCl 15% injectable

Select language:
On this page

    Last updated: February 2024


    Prescription under medical supervision


    This drug should only be used by well-trained personnel in well-equipped hospitals.



    • Treatment of severe hypokalaemia (arrhythmia, marked muscular weakness and/or serum potassium level ≤ 2.5 mmol/litre)

    Forms and strengths, route of administration

    • Ampoule containing 15% potassium chloride hypertonic solution (150 mg/ml, 10 ml = 2 mmol/ml), i.e. 1.5 g of potassium chloride (KCl) per 10 ml ampoule
    • Ionic composition:
      • potassium (K+): 20 mmol per 10 ml ampoule (20 mEq)
      • chloride (Cl): 20 mmol per 10 ml ampoule (20 mEq)
    • Check concentration before use: potassium chloride also comes in ampoules containing 7.5%, 10%, 11.2% and 20% solutions.
    • Potassium chloride must always be administered by slow IV infusion, diluted in 0.9% sodium chloride.
    • For dilution:
      • The potassium concentration in the infusion fluid should not exceed 40 mmol/litre.
      • Mix thoroughly the potassium and the 0.9% sodium chloride solution by inverting at least 5 times the infusion bottle or bag.

    Dosage and duration

    Dosage depends on the severity of hypokalaemia and the patient’s underlying condition. For information:

    • Child over one month: 0.2 mmol/kg/hour for 3 hours
      Each mmol of potassium is diluted in 25 ml of 0.9% sodium chloride.



    10 kg

    0.2 (mmol) x 10 (kg) = 2 mmol/hour x 3 hours = 6 mmol
    6 mmol (= 3 ml of 15% KCl solution) diluted in 150 ml of NaCl 0.9% and administered over 3 hours

    15 kg

    0.2 (mmol) x 15 (kg) = 3 mmol/hour x 3 hours = 9 mmol
    9 mmol (= 4.5 ml of 15% KCl solution) diluted in 225 ml of NaCl 0.9% and administered over 3 hours


    • Adult: 40 mmol (= 2 ampoules of 10 ml of 15% KCl) in one litre of 0.9% sodium chloride, to be administered over 4 hours


    Do not exceed 10 mmol/hour. The infusion may be repeated if severe symptoms persist or if the serum potassium level remains < 3 mmol/litre.

    Contra-indications, adverse effects, precautions

    • Administer with caution to older adults.
    • Administer with caution and reduce the dose in patients with renal impairment (increased risk of hyperkalaemia).
    • May cause:
      • pain at infusion site, venous irritation and phlebitis (use a large peripheral vein to reduce these risks);
      • in the event of too rapid administration or overdose: hyperkalaemia, cardiac conduction and rhythm disorders, potentially fatal;
      • in the event of extravasation: necrosis.
    • Monitor closely:
      • infusion rate; use an infusion pump or syringe pump if possible to prevent unintentional bolus;
      • infusion site for redness and inflammation.
    • Monitor electrolytes if possible to determine the need for further infusions and to avoid hyperkalaemia.


    • Higher dose or infusion rate requires continuous electrocardiogram monitoring.
    • Potassium chloride is also used to prevent hypokalaemia in patients unable to meet their daily requirements by oral route : daily K+ requirements are 2 to 3 mmol/kg daily in children and 1 to 2 mmol/kg daily in adults.
    • A 7.5% potassium solution contains 1 mmol of K+/ml; a 10% solution contains 1.34 mmol/ml ; a 11.2% solution contains 1.5 mmol of K+/ml; a 20% solution contains 2.68 mmol of K+/ml.


    Below 25 °C